- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05391620
The Effect of the 3/7 vs 3X9 Method in Resistance Training on Metabolic Stress in Cardiac Rehabilitation
Acute Effects of the 3/7 Method and 3X9 Method in Resistance Training on Testosterone, Glucocorticoid Cortisol, Growth Hormone and Lactate in Heart Failure and Coronary Artery Disease During Cardiac Rehabilitation
The study proposes to measure the effect of resitance training (RT) (3/7 method) on biological markers of muscle hypertrophy in a cardiac population.
3/7 method consisting of five sets of an increasing number of repetitions (3 to 7) during successive sets and brief inter-set intervals (15 s). This method is compare to 3X9 method, 3 series of 9 repetitions with inter-set (1min).The training exercise consisted of contraction on machine (leg press, triceps press, leg curl, traction, leg extension) with load of ~ 70% of one repetition maximal (1RM).
Before these trainings all subject perform HIIT on bicycles (2 min high intensity (80% Wmax) and 2 min low intensity (50% Wmax) during 30 minutes.
The investigators collect blood sample before exercice, after HIIT and after RT.
It is randomized cross-over study.
Study Overview
Status
Intervention / Treatment
Detailed Description
The subjects come on two different days minimum 2 days and maximum 10 days between the two tests. They were instructed to avoid exercise the day before they participated in the study.
The investigators collect blood 2 minutes after endurance training (HIIT) and 2 min after RT training.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Brussels, Belgium, 1070
- Erasme Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Clinical Coronary artery diseases
- Heart failure with reduced ejection fraction
Exclusion Criteria:
- angina
- acutely decompensated heart failure
- electrocardiographic evidence of ischemia
- significant valvular disease
- orthopedic/neurologic disorders that limited exercise
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: CAD group
Coronary artery diseases
|
HIIT ( 2 min 80% wmax: 2 min 50% wmax) during 30 minutes 3/7 method 3 rep (15 sec of rest), 4 rep (15 sec), 5 rep (15 sec), 6 rep (15 sec), 7 rep. (total volume : 25 repetitions) at 70 of 1 repetition Leg press, Dips Press, Leg curl, Traction and Leg extension. 1 minute between each machine is planned.
Other Names:
HIIT ( 2 min 80% wmax: 2 min 50% wmax) during 30 minutes 3X9 method 9 rep 1 minute of rest, 9 rep (1 min) and 9 rep (total volume : 27 repetitions) at 70 of 1 repetition Leg press, Dips Press, Leg curl, Traction and Leg extension. 1 minute between each machine is planned
Other Names:
|
|
Experimental: HFrEF group
Heart Failure with reduced Ejection Fraction
|
HIIT ( 2 min 80% wmax: 2 min 50% wmax) during 30 minutes 3/7 method 3 rep (15 sec of rest), 4 rep (15 sec), 5 rep (15 sec), 6 rep (15 sec), 7 rep. (total volume : 25 repetitions) at 70 of 1 repetition Leg press, Dips Press, Leg curl, Traction and Leg extension. 1 minute between each machine is planned.
Other Names:
HIIT ( 2 min 80% wmax: 2 min 50% wmax) during 30 minutes 3X9 method 9 rep 1 minute of rest, 9 rep (1 min) and 9 rep (total volume : 27 repetitions) at 70 of 1 repetition Leg press, Dips Press, Leg curl, Traction and Leg extension. 1 minute between each machine is planned
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Lactate
Time Frame: within 2 minutes after TR training session on day 1
|
mmol/l
|
within 2 minutes after TR training session on day 1
|
|
change in Testosterone
Time Frame: within 2 minutes after TR training session on day 1
|
nmol/l
|
within 2 minutes after TR training session on day 1
|
|
change Glucocorticoid Cortisol
Time Frame: within 2 minutes after TR training session on day 1
|
nmol/l
|
within 2 minutes after TR training session on day 1
|
|
change in Growth Hormone
Time Frame: within 2 minutes after TR training session on day 1
|
ng/ml
|
within 2 minutes after TR training session on day 1
|
|
change in ph
Time Frame: within 2 minutes after TR training session on day 1
|
venoust
|
within 2 minutes after TR training session on day 1
|
|
change PCO2 venoust
Time Frame: within 2 minutes after TR training session on day 1
|
mm Hg
|
within 2 minutes after TR training session on day 1
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Borg scale
Time Frame: within 4 minutes after TR training session on day 1
|
Borg Rating of Perceived Exertion - Borg modified (0 = no exertion at all -10 maximal exertion)
|
within 4 minutes after TR training session on day 1
|
|
Pleasure of the session scale
Time Frame: within 4 minutes after TR training session on day 1
|
0 = worse 10 = better
|
within 4 minutes after TR training session on day 1
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Philippe van de borne, Professor, Erasme University Hospital, Université Libre de Bruxelles, Brussels, Belgium
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2020276
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Coronary Artery Disease
-
Infirmerie Protestante de LyonRecruitingCoronary Artery Bypass | Coronary Artery Disease(CAD) | Off Pump Coronary Artery Bypass Surgery | Hemodynamic Optimization | Hemodynamic Management | Off Pump Coronary Artery Bypass Graft | Coronary Artery Disease With Need for Bypass Surgery | NoradrenalineFrance
-
Shanghai Bluesail Boyuan Medical Technology Co....Not yet recruitingCoronary Artery Disease | Coronary Artery Calcification | Severe Coronary Artery DiseaseChina
-
I.R.C.C.S Ospedale Galeazzi-Sant'AmbrogioCompletedCoronary Artery Disease (CAD) | Atherosclerosis of Coronary ArteryItaly
-
Scitech Produtos Medicos SANot yet recruitingCoronary Artery Disease (CAD) | Multivessel Coronary Artery Disease | Complex Coronary Lesions | Calcific Coronary Arteriosclerosis | Small Vessel Ischemic Disease | Stenosis CoronaryBrazil
-
Istanbul Mehmet Akif Ersoy Educational and Training...Bakirkoy Dr. Sadi Konuk Research and Training Hospital; Ege University; Istanbul... and other collaboratorsActive, not recruitingCoronary Artery Disease (CAD) | Coronary Bifurcation Lesion | Left Main Coronary Artery StenosisTurkey (Türkiye)
-
University Medical Centre LjubljanaRecruitingCoronary Artery Disease With Myocardial InfarctionSlovenia
-
EBI Anti Sepsis BVCR2O B.V.Not yet recruitingCoronary Artery Disease (CAD) | Coronary Artery Bypass Graft Surgery(CABG)United States, Netherlands, Belgium, United Kingdom
-
Mahidol UniversityThe Princess Mantarop Kamalas Foundation, The Nurses' Association of Thailand and other collaboratorsActive, not recruitingCoronary Artery Disease (CAD) | Postoperative Recovery | Coronary Artery Bypass Graft (CABG)Thailand
-
Fundación EPICActive, not recruitingCoronary Artery Disease | Left Main Coronary Artery Disease | Left Main Coronary Artery Stenosis | Restenosis, CoronarySpain
-
Elixir Medical CorporationIstituto Clinico HumanitasActive, not recruitingCoronary Artery Disease | Chronic Total Occlusion of Coronary Artery | Multi Vessel Coronary Artery Disease | Bifurcation of Coronary Artery | Long Lesions Coronary Artery DiseaseItaly
Clinical Trials on Cardiac rehabilitation with 3/7 method
-
Université Libre de BruxellesCompletedCoronary Artery Disease | Heart FailureBelgium
-
Cairo UniversityNational Heart Institute, EgyptCompletedChronic Heart FailureEgypt
-
Ant ShepherdHampshire Hospitals NHS Foundation TrustUnknown
-
Riphah International UniversityRecruitingPercutaneous CORONARY INTERVENTIONPakistan
-
Samsung Medical CenterCompletedCongenital Heart DiseaseKorea, Republic of
-
ElsanRecruiting
-
Cairo UniversityEnrolling by invitationCoronary Artery Bypass Grafting | Post Coronary Artery Bypass GraftingEgypt
-
Centre Hospitalier Universitaire de Saint EtienneCompletedMyocardial Infarction | Coronary Artery DiseaseFrance
-
Riphah International UniversityCompletedCoronary Artery DiseasePakistan
-
Erzurum Technical UniversityActive, not recruitingPatients With Total Knee ArthroplastyTurkey